Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids
Background Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup presents as an endobronchial tumour. Surgical resection is considered the standard approach because of its metastatic potential and the possibility of an iceberg phenomenon for the endobronchial subgroup. Advance...
Gespeichert in:
Veröffentlicht in: | Thorax 2015-05, Vol.70 (5), p.468-472 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 472 |
---|---|
container_issue | 5 |
container_start_page | 468 |
container_title | Thorax |
container_volume | 70 |
creator | Brokx, Hes A P Paul, Marinus A Postmus, Pieter E Sutedja, Thomas G |
description | Background Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup presents as an endobronchial tumour. Surgical resection is considered the standard approach because of its metastatic potential and the possibility of an iceberg phenomenon for the endobronchial subgroup. Advances in non-invasive and minimally invasive technologies seem to justify a more lung parenchyma-sparing approach. Methods In patients presenting with bronchial carcinoids, initial bronchoscopic treatment (IBT) is first attempted for complete tumour eradication and sufficient tissue sampling for the proper differentiation of typical (TC) versus atypical (AC) histological type. Furthermore in cases with postobstruction problems the desobstruction is aimed at improving the patient's condition and by that alleviate surgery if that is needed. High resolution CT is performed 6 weeks post IBT to determine local tumour growth. Surgical resection follows in case of extraluminal disease, residual carcinoid inaccessible for IBT, or late recurrences not salvaged by repeat IBT. Results Minimum follow-up was 5 years from start of treatment for 112 patients (65 women, 47 men), with a median age of 47 years (range 16–77 years). Eighty-three patients (74%) had TC, and 29 (26%) AC. IBT only was ultimately curative in 42% of the cases (47/112): 42 TC, 5 AC. Disease-specific mortality including surgical mortality has been 2.6% (3/112) in patients with extraluminal carcinoids (3 AC). Conclusions IBT, if with unsuccessful rescue surgery, is justifiable with excellent long-term outcome. IBT made surgery unnecessary in 42% of the cases. Iceberg phenomenon and metastatic potential in this group of patients with bronchial carcinoids are clinically insignificant. |
doi_str_mv | 10.1136/thoraxjnl-2014-206753 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1673371730</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1673371730</sourcerecordid><originalsourceid>FETCH-LOGICAL-b425t-53634ab199c86894b19578fbdf519888ea2eac345fc7a42d2c5419c88db3b6453</originalsourceid><addsrcrecordid>eNqNkU9P3DAQxS1UxC60H4HKUi9cXOz4b44VagFppV7gbBzHYb1K7NR2RPn2GO2yh556mRmNfu9pNA-AS4K_E0LFddnGZP7uwogaTFgtQnJ6AtaECYVo04pPYI0xw0hQKVbgPOcdxlgRIs_AquFSSq7EGjxtYnhGxaUJDnEc4wtaZmiGuoCDT7mg0QcHuxSD3cZs4-wtLFuXzPwKfYCzKd6FkuGLL9sD5s0IrUnWh-j7_BmcDmbM7suhX4DHXz8fbu7Q5vft_c2PDepYwwviVFBmOtK2VgnVsjpxqYauHzhplVLONM5YyvhgpWFN31jOSGVV39FOME4vwNXed07xz-Jy0ZPP1o2jCS4uWRMhKZVEUlzRb_-gu7ikUK_TRCqiGiGFqBTfUzbFnJMb9Jz8ZNKrJli_R6CPEej3CPQ-gqr7enBfusn1R9XHzyuA90A37f7T8w2XC5UL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781826766</pqid></control><display><type>article</type><title>Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>Alma/SFX Local Collection</source><creator>Brokx, Hes A P ; Paul, Marinus A ; Postmus, Pieter E ; Sutedja, Thomas G</creator><creatorcontrib>Brokx, Hes A P ; Paul, Marinus A ; Postmus, Pieter E ; Sutedja, Thomas G</creatorcontrib><description>Background Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup presents as an endobronchial tumour. Surgical resection is considered the standard approach because of its metastatic potential and the possibility of an iceberg phenomenon for the endobronchial subgroup. Advances in non-invasive and minimally invasive technologies seem to justify a more lung parenchyma-sparing approach. Methods In patients presenting with bronchial carcinoids, initial bronchoscopic treatment (IBT) is first attempted for complete tumour eradication and sufficient tissue sampling for the proper differentiation of typical (TC) versus atypical (AC) histological type. Furthermore in cases with postobstruction problems the desobstruction is aimed at improving the patient's condition and by that alleviate surgery if that is needed. High resolution CT is performed 6 weeks post IBT to determine local tumour growth. Surgical resection follows in case of extraluminal disease, residual carcinoid inaccessible for IBT, or late recurrences not salvaged by repeat IBT. Results Minimum follow-up was 5 years from start of treatment for 112 patients (65 women, 47 men), with a median age of 47 years (range 16–77 years). Eighty-three patients (74%) had TC, and 29 (26%) AC. IBT only was ultimately curative in 42% of the cases (47/112): 42 TC, 5 AC. Disease-specific mortality including surgical mortality has been 2.6% (3/112) in patients with extraluminal carcinoids (3 AC). Conclusions IBT, if with unsuccessful rescue surgery, is justifiable with excellent long-term outcome. IBT made surgery unnecessary in 42% of the cases. Iceberg phenomenon and metastatic potential in this group of patients with bronchial carcinoids are clinically insignificant.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thoraxjnl-2014-206753</identifier><identifier>PMID: 25777586</identifier><identifier>CODEN: THORA7</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Adolescent ; Adult ; Aged ; Bronchial Neoplasms - mortality ; Bronchial Neoplasms - pathology ; Bronchial Neoplasms - surgery ; Bronchoscopy ; Carcinoid Tumor - mortality ; Carcinoid Tumor - pathology ; Carcinoid Tumor - surgery ; Classification ; Clinical Protocols ; Female ; Follow-Up Studies ; Histology ; Humans ; Lymphatic system ; Male ; Middle Aged ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - surgery ; Neoplasm, Residual ; Patients ; Pneumonectomy ; Surgery ; Surveillance ; Treatment Outcome ; Tumors ; Young Adult</subject><ispartof>Thorax, 2015-05, Vol.70 (5), p.468-472</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><rights>Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b425t-53634ab199c86894b19578fbdf519888ea2eac345fc7a42d2c5419c88db3b6453</citedby><cites>FETCH-LOGICAL-b425t-53634ab199c86894b19578fbdf519888ea2eac345fc7a42d2c5419c88db3b6453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://thorax.bmj.com/content/70/5/468.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttps://thorax.bmj.com/content/70/5/468.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3194,23569,27922,27923,77370,77401</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25777586$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brokx, Hes A P</creatorcontrib><creatorcontrib>Paul, Marinus A</creatorcontrib><creatorcontrib>Postmus, Pieter E</creatorcontrib><creatorcontrib>Sutedja, Thomas G</creatorcontrib><title>Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids</title><title>Thorax</title><addtitle>Thorax</addtitle><description>Background Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup presents as an endobronchial tumour. Surgical resection is considered the standard approach because of its metastatic potential and the possibility of an iceberg phenomenon for the endobronchial subgroup. Advances in non-invasive and minimally invasive technologies seem to justify a more lung parenchyma-sparing approach. Methods In patients presenting with bronchial carcinoids, initial bronchoscopic treatment (IBT) is first attempted for complete tumour eradication and sufficient tissue sampling for the proper differentiation of typical (TC) versus atypical (AC) histological type. Furthermore in cases with postobstruction problems the desobstruction is aimed at improving the patient's condition and by that alleviate surgery if that is needed. High resolution CT is performed 6 weeks post IBT to determine local tumour growth. Surgical resection follows in case of extraluminal disease, residual carcinoid inaccessible for IBT, or late recurrences not salvaged by repeat IBT. Results Minimum follow-up was 5 years from start of treatment for 112 patients (65 women, 47 men), with a median age of 47 years (range 16–77 years). Eighty-three patients (74%) had TC, and 29 (26%) AC. IBT only was ultimately curative in 42% of the cases (47/112): 42 TC, 5 AC. Disease-specific mortality including surgical mortality has been 2.6% (3/112) in patients with extraluminal carcinoids (3 AC). Conclusions IBT, if with unsuccessful rescue surgery, is justifiable with excellent long-term outcome. IBT made surgery unnecessary in 42% of the cases. Iceberg phenomenon and metastatic potential in this group of patients with bronchial carcinoids are clinically insignificant.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Bronchial Neoplasms - mortality</subject><subject>Bronchial Neoplasms - pathology</subject><subject>Bronchial Neoplasms - surgery</subject><subject>Bronchoscopy</subject><subject>Carcinoid Tumor - mortality</subject><subject>Carcinoid Tumor - pathology</subject><subject>Carcinoid Tumor - surgery</subject><subject>Classification</subject><subject>Clinical Protocols</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Histology</subject><subject>Humans</subject><subject>Lymphatic system</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Neoplasm, Residual</subject><subject>Patients</subject><subject>Pneumonectomy</subject><subject>Surgery</subject><subject>Surveillance</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><subject>Young Adult</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkU9P3DAQxS1UxC60H4HKUi9cXOz4b44VagFppV7gbBzHYb1K7NR2RPn2GO2yh556mRmNfu9pNA-AS4K_E0LFddnGZP7uwogaTFgtQnJ6AtaECYVo04pPYI0xw0hQKVbgPOcdxlgRIs_AquFSSq7EGjxtYnhGxaUJDnEc4wtaZmiGuoCDT7mg0QcHuxSD3cZs4-wtLFuXzPwKfYCzKd6FkuGLL9sD5s0IrUnWh-j7_BmcDmbM7suhX4DHXz8fbu7Q5vft_c2PDepYwwviVFBmOtK2VgnVsjpxqYauHzhplVLONM5YyvhgpWFN31jOSGVV39FOME4vwNXed07xz-Jy0ZPP1o2jCS4uWRMhKZVEUlzRb_-gu7ikUK_TRCqiGiGFqBTfUzbFnJMb9Jz8ZNKrJli_R6CPEej3CPQ-gqr7enBfusn1R9XHzyuA90A37f7T8w2XC5UL</recordid><startdate>201505</startdate><enddate>201505</enddate><creator>Brokx, Hes A P</creator><creator>Paul, Marinus A</creator><creator>Postmus, Pieter E</creator><creator>Sutedja, Thomas G</creator><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>201505</creationdate><title>Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids</title><author>Brokx, Hes A P ; Paul, Marinus A ; Postmus, Pieter E ; Sutedja, Thomas G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b425t-53634ab199c86894b19578fbdf519888ea2eac345fc7a42d2c5419c88db3b6453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Bronchial Neoplasms - mortality</topic><topic>Bronchial Neoplasms - pathology</topic><topic>Bronchial Neoplasms - surgery</topic><topic>Bronchoscopy</topic><topic>Carcinoid Tumor - mortality</topic><topic>Carcinoid Tumor - pathology</topic><topic>Carcinoid Tumor - surgery</topic><topic>Classification</topic><topic>Clinical Protocols</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Histology</topic><topic>Humans</topic><topic>Lymphatic system</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Neoplasm, Residual</topic><topic>Patients</topic><topic>Pneumonectomy</topic><topic>Surgery</topic><topic>Surveillance</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brokx, Hes A P</creatorcontrib><creatorcontrib>Paul, Marinus A</creatorcontrib><creatorcontrib>Postmus, Pieter E</creatorcontrib><creatorcontrib>Sutedja, Thomas G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brokx, Hes A P</au><au>Paul, Marinus A</au><au>Postmus, Pieter E</au><au>Sutedja, Thomas G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2015-05</date><risdate>2015</risdate><volume>70</volume><issue>5</issue><spage>468</spage><epage>472</epage><pages>468-472</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><coden>THORA7</coden><abstract>Background Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup presents as an endobronchial tumour. Surgical resection is considered the standard approach because of its metastatic potential and the possibility of an iceberg phenomenon for the endobronchial subgroup. Advances in non-invasive and minimally invasive technologies seem to justify a more lung parenchyma-sparing approach. Methods In patients presenting with bronchial carcinoids, initial bronchoscopic treatment (IBT) is first attempted for complete tumour eradication and sufficient tissue sampling for the proper differentiation of typical (TC) versus atypical (AC) histological type. Furthermore in cases with postobstruction problems the desobstruction is aimed at improving the patient's condition and by that alleviate surgery if that is needed. High resolution CT is performed 6 weeks post IBT to determine local tumour growth. Surgical resection follows in case of extraluminal disease, residual carcinoid inaccessible for IBT, or late recurrences not salvaged by repeat IBT. Results Minimum follow-up was 5 years from start of treatment for 112 patients (65 women, 47 men), with a median age of 47 years (range 16–77 years). Eighty-three patients (74%) had TC, and 29 (26%) AC. IBT only was ultimately curative in 42% of the cases (47/112): 42 TC, 5 AC. Disease-specific mortality including surgical mortality has been 2.6% (3/112) in patients with extraluminal carcinoids (3 AC). Conclusions IBT, if with unsuccessful rescue surgery, is justifiable with excellent long-term outcome. IBT made surgery unnecessary in 42% of the cases. Iceberg phenomenon and metastatic potential in this group of patients with bronchial carcinoids are clinically insignificant.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>25777586</pmid><doi>10.1136/thoraxjnl-2014-206753</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0040-6376 |
ispartof | Thorax, 2015-05, Vol.70 (5), p.468-472 |
issn | 0040-6376 1468-3296 |
language | eng |
recordid | cdi_proquest_miscellaneous_1673371730 |
source | MEDLINE; BMJ Journals - NESLi2; Alma/SFX Local Collection |
subjects | Adolescent Adult Aged Bronchial Neoplasms - mortality Bronchial Neoplasms - pathology Bronchial Neoplasms - surgery Bronchoscopy Carcinoid Tumor - mortality Carcinoid Tumor - pathology Carcinoid Tumor - surgery Classification Clinical Protocols Female Follow-Up Studies Histology Humans Lymphatic system Male Middle Aged Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - surgery Neoplasm, Residual Patients Pneumonectomy Surgery Surveillance Treatment Outcome Tumors Young Adult |
title | Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T23%3A35%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20follow-up%20after%20first-line%20bronchoscopic%20therapy%20in%20patients%20with%20bronchial%20carcinoids&rft.jtitle=Thorax&rft.au=Brokx,%20Hes%20A%20P&rft.date=2015-05&rft.volume=70&rft.issue=5&rft.spage=468&rft.epage=472&rft.pages=468-472&rft.issn=0040-6376&rft.eissn=1468-3296&rft.coden=THORA7&rft_id=info:doi/10.1136/thoraxjnl-2014-206753&rft_dat=%3Cproquest_cross%3E1673371730%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781826766&rft_id=info:pmid/25777586&rfr_iscdi=true |